In addition, we found that the expression levels of VEGFA, MMP2, and MMP9 were, unsurprisingly, downregulated after inhibition of AKT signaling, even in L1‐overexpressing glioma cells (Fig. 7D). The gene discussed is MMP9; the disease is central nervous system cancer.